REALWAVE NEUROPATHY TREATMENT CENTERS Trademark

Trademark Overview


On Wednesday, September 15, 2021, a trademark application was filed for REALWAVE NEUROPATHY TREATMENT CENTERS with the United States Patent and Trademark Office. The USPTO has given the REALWAVE NEUROPATHY TREATMENT CENTERS trademark a serial number of 97027766. The federal status of this trademark filing is REGISTERED as of Tuesday, October 25, 2022. This trademark is owned by Amylase Technologies LLC. The REALWAVE NEUROPATHY TREATMENT CENTERS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnosis and treatment of peripheral neuropathy; Medical diagnosis of peripheral neuropathy; Medical evaluation of peripheral neuropathy; Medical services, namely, evaluation and treatment of peripheral neuropathy; Medical testing for diagnostic or treatment purposes in the field of peripheral neuropathy; Medical treatment of peripheral neuropathy
realwave neuropathy treatment centers

General Information


Serial Number97027766
Word MarkREALWAVE NEUROPATHY TREATMENT CENTERS
Filing DateWednesday, September 15, 2021
Status700 - REGISTERED
Status DateTuesday, October 25, 2022
Registration Number6883567
Registration DateTuesday, October 25, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements


Description of MarkThe mark consists of the terms "REAL WAVE" in a distinctive font in which the letter "A" appears as an inverted "V", the letter "W" is depicted in a stylized form representing a sine wave, the term "REAL" appears above the term "WAVE", and the outer arms of the letter "W" in WAVE partially overlaps the "R" and "A" in "REAL", all above a horizontal line below which appears the term "NEUROPATHY", below which appear the terms "TREATMENT CENTERS".
Pseudo MarkREAL WAVE NEUROPATHY TREATMENT CENTERS
Goods and ServicesMedical diagnosis and treatment of peripheral neuropathy; Medical diagnosis of peripheral neuropathy; Medical evaluation of peripheral neuropathy; Medical services, namely, evaluation and treatment of peripheral neuropathy; Medical testing for diagnostic or treatment purposes in the field of peripheral neuropathy; Medical treatment of peripheral neuropathy
Disclaimer with Predetermined Text"NEUROPATHY TREATMENT CENTERS"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code044
First Use Anywhere DateSaturday, July 31, 2021
First Use In Commerce DateSaturday, July 31, 2021

Trademark Owner History


Party NameAmylase Technologies LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBillings, MT 59102

Party NameAmylase Technologies LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBillings, MT 59102

Party NameAmylase Technologies LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBillings, MT 59102

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 21, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, June 21, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 21, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, June 21, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, June 16, 2022ASSIGNED TO EXAMINER
Friday, October 22, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 18, 2021NEW APPLICATION ENTERED IN TRAM